Skip to content

Comparison of cardiovascular response to the laryngoscopy and tracheal intubation after induction of anesthesia by propofol or etomidate

Comparison of cardiovascular response to the laryngoscopy and tracheal intubation after induction of anesthesia by propofol or etomidate

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201304166617N2
Enrollment
50
Registered
2013-05-03
Start date
2012-10-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia. Other complications of anaesthesia

Interventions

Intervention 1: Propofol, 2.5 mg/kg within 30 seconds
IV. Intervention 2: Etomidate, 0.3 mg/kg within 30 seconds
Treatment - Drugs
Propofol, 2.5 mg/kg within 30 seconds

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: being aged from 18 to 45 years old; having no underlying diseases; being of ASA 1 classification; being an applicant for elective orthopedic surgery on upper and lower extremities; not being allergic to anesthetic drugs; not having any expected problems of the airway; receiving no narcotics or sedative drugs before the anesthesia and not being hemodynamic unstablility before the anesthesia. Patients who were a 4 grade after the induction of anesthesia and laryngoscopy, or their laryngoscopy were lasted longer than 30 seconds, or were not anesthetized using the mentioned dose of drugs and received higher doses, were excluded from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure. Timepoint: Before intervention, at laryngoscopy time and 1 , 3 ,5 , 10 min after drug injection. Method of measurement: mm-hg, sphygmomanometer.;Diastolic bllod pressure. Timepoint: Before intervention, at laryngoscopy time and 1 , 3 ,5 , 10 min after drug injection. Method of measurement: mm-hg, sphygmomanometer.;Mean arterial pressure. Timepoint: Before intervention, at laryngoscopy time and 1 , 3 ,5 , 10 min after drug injection. Method of measurement: mm-hg, sphygmomanometer.;Heart rate. Timepoint: Before intervention, at laryngoscopy time and 1 , 3 ,5 , 10 min after drug injection. Method of measurement: ECG monitor.;O2 saturation. Timepoint: Before intervention, at laryngoscopy time and 1 , 3 ,5 , 10 min after drug injection. Method of measurement: Pulseoxymeter.

Secondary

MeasureTime frame
Hypotension. Timepoint: Other complications of anaesthesia. Method of measurement: mm-Hg, sphygmomanometer.;Hypertension. Timepoint: Other complications of anaesthesia. Method of measurement: mm-Hg, sphygmomanometer.;Tachycardia. Timepoint: Other complications of anaesthesia. Method of measurement: ECG monitor.;Bradycardia. Timepoint: Before intervention, at laryngoscopy time and 1 , 3 ,5 , 10 min after drug injection. Method of measurement: ECG monitor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrdad Masoudifar

Isfahan University of Medical Sciences

masoudifar@med.mui.ac.ir+98 31 1233 0091

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026